Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
Crossref DOI link: https://doi.org/10.1007/s10198-014-0594-4
Published Online: 2014-05-16
Published Print: 2014-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baji, Petra
Péntek, Márta
Czirják, László
Szekanecz, Zoltán
Nagy, György
Gulácsi, László
Brodszky, Valentin
Text and Data Mining valid from 2014-05-01
Version of Record valid from 2014-05-01
Article History
Received: 4 February 2014
Accepted: 31 March 2014
First Online: 16 May 2014